The future of ACT is promising, with ongoing research aimed at improving its efficacy and safety. Advances in genetic engineering and biotechnology are likely to lead to more sophisticated and effective therapies. Clinical trials continue to explore new ways to optimize this treatment and expand its use to a broader range of cancers.
